Stay updated on Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.

Latest updates to the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedA new revision entry, Revision: v3.5.3, was added to the study's record history, indicating the latest version of the study record. The update replaces the previous v3.5.2 entry in the history.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page history shows a new site revision (v3.5.2) and removal of the previous revision (v3.5.0).SummaryDifference0.1%

- Check57 days agoChange DetectedRevision: v3.5.0 was added to the history and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded a Study Status section to the Record History page and updated to Revision: v3.4.3 (2026-03-09). The previous revision v3.4.2 (2025-12-26) was deleted.SummaryDifference0.3%

- Check93 days agoChange DetectedThe page history shows Revision: v3.4.2 added and Revision: v3.4.1 removed, indicating a minor update to the history entries rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check100 days agoChange DetectedRevision: v3.4.1 has been added to the history, and the notices about funding lapse and Revision: v3.4.0 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.